| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 433 | 1,508 | 596 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 433 | 1,508 | 596 | | | Operating Expenses | | Research Development | 22,575 | 12,420 | 11,912 | | Selling General and Administrative | 3,060 | 2,788 | 2,879 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (25,202) | (13,700) | (14,195) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (25,202) | (13,700) | (14,195) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (25,202) | (13,700) | (14,195) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (25,202) | (13,700) | (14,195) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (25,202) | (13,700) | (14,195) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($25,202) | ($13,700) | ($14,195) |
|
0.22% Nasdaq 
0.01 (1.37%) 
Income Statement
